| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |